Product Code: SR112024A5168
The global dialyzer market size reached US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032.
A dialyzer, also known as an artificial kidney, is an apparatus manufactured using a thin and fibrous material to form a semipermeable membrane, which allows smaller particles and liquids to pass through. It is a cost-effective solution that removes excess fluids and wastes from the blood when kidneys are unable to function properly and prevents accumulation of salt and poisoning. It offers several advantages, such as less waste disposal, minimizing environmental impact, decreasing the frequency of first use syndrome, and improving biocompatibility. As a result, it finds extensive applications in in-center dialysis and home dialysis across the globe.
Dialyzer Market Trends:
At present, there is a rise in the prevalence of diabetes, hypertension, heart disease, and end-stage renal diseases (ESRD) among individuals. This, along with the growing geriatric population around the world, represents one of the key factors driving the market. Moreover, the increasing funding on improving dialysis products and services by governments of several countries is propelling the growth of the market. In addition, the shortage of kidneys for transplantation across the globe is offering lucrative growth opportunities to key market players. Besides this, the availability of trained medical staff in dialysis centers that provide better services to the patient is positively influencing the market. Additionally, the rising utilization of novel products to treat chronic kidney conditions is catalyzing the demand for dialyzers worldwide. Apart from this, the higher efficiency of high-flux dialyzers to remove large size toxin molecules during the hemodialysis is bolstering the growth of the market. Other growth-inducing factors are the expanding healthcare industry, rising medical tourism, increasing reimbursement policies and technological advancements in the product production process.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global dialyzer market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, usage type and end user.
Breakup by Type:
High-Flux Dialyzer
Low-Flux Dialyzer
Breakup by Usage Type:
Disposable
Reusable
Breakup by End User:
Hospitals and Clinics
Ambulatory Surgical Centers
Home Care Settings
Dialysis Centers
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Browndove Healthcare (P) Ltd., Cantel Medical Corporation (Steris plc), Dialife SA, Farmasol, Fresenius Medical Care AG & Co. KGaA, Medica S.p.A., Medtronic plc, Nikkiso Co. Ltd., Nipro Corporation, Shandong Weigao Group Medical Polymer Co. Ltd. and Toray Industries Inc.
Key Questions Answered in This Report
- 1. What was the size of the global dialyzer market in 2023?
- 2. What is the expected growth rate of the global dialyzer market during 2024-2032?
- 3. What are the key factors driving the global dialyzer market?
- 4. What has been the impact of COVID-19 on the global dialyzer market?
- 5. What is the breakup of the global dialyzer market based on the type?
- 6. What is the breakup of the global dialyzer market based on the usage type?
- 7. What is the breakup of the global dialyzer market based on the end user?
- 8. What are the key regions in the global dialyzer market?
- 9. Who are the key players/companies in the global dialyzer market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Dialyzer Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 High-Flux Dialyzer
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Low-Flux Dialyzer
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Usage Type
- 7.1 Disposable
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Reusable
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals and Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Ambulatory Surgical Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Home Care Settings
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Dialysis Centers
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Asahi Kasei Corporation
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 B. Braun Melsungen AG
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 SWOT Analysis
- 14.3.3 Baxter International Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Browndove Healthcare (P) Ltd.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Cantel Medical Corporation (Steris plc)
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 SWOT Analysis
- 14.3.6 Dialife SA
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Farmasol
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Fresenius Medical Care AG & Co. KGaA
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Medica S.p.A.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Medtronic plc
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Nikkiso Co. Ltd.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Nipro Corporation
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.13 Shandong Weigao Group Medical Polymer Co. Ltd.
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.13.3 Financials
- 14.3.13.4 SWOT Analysis
- 14.3.14 Toray Industries Inc.
- 14.3.14.1 Company Overview
- 14.3.14.2 Product Portfolio
- 14.3.14.3 Financials
- 14.3.14.4 SWOT Analysis